SEVERE COURSE OF BRONCHIAL ASTHMA PROGNOSING
Journal Title: Астма и Аллергия - Year 2019, Vol 1, Issue 1
Abstract
Aim of study – to carry out prognоsis of the influence of risk factors on uncontrolled course of bronchial asthma (BA), decrease of tolerance to physical activity, deterioration of quality of life, development of lung hyperinflation, occurrence of severe exacerbations of asthma. Methods. 160 patients with severe BA were examined, in which at the specialized medical care level the final phenotypes of the disease were established: allergic asthma - in 60,0% of patients (with allergic rhinitis – 34,4 %, polyposis – 3,8 %, atopic dermatitis – 0,6 %) and non-allergic asthma – at 40,0 %. Among these patients, other phenotypes of severe BA were distinguished: BA with a late onset – 40,6 %, BA with obesity – 33,1 % and BA with fixed bronchial obstruction – in 14,4 % of patients. Asthma associated with chronic obstructive pulmonary disease (COPD) was detected in 20,6 % of patients, BA with concomitant diseases – cardiovascular diseases 58,8 %, sleep obstructive apnea-hypopnea syndrome (SOAHS) – 12,5 %, gastro-esophageal reflux disease (GERD) – 10,0 %. Data collection and their mathematical processing were carried out with the help of licensed software products included in the package Micrоsoft Office Professional 2003, license Russian Academic OPEN No Level No 17016297. Statistical analysis was carriedout with the help of mathematical and statistical capabilities of MS Excel. In order to assess the risk of the presence of certain features among the observation groups, the odds ratio and its 95% confidence interval were calculated (CI). To assess the generalized probability of development of individual events under the influence of several risk factors, the Cochran-Mantel-Hensel criterion was used with the help of software Review Manager (RevMan 5.3). Results. As a result of the research, it was found that the prognosis of the severe course of bronchial asthma can reveal the most important factors that affect the severe course of asthma. The severity of the asthma course depends on: the phenotype of the disease, pulmonary function violation, type of inflammation in the tracheobronchial tree, late onset asthma, severe exacerbations, allergic and related pathologies. Therefore timely detection of the phenotype of severe asthma, allergic and concomitant diseases is a topical issue of modern pulmonology. It was determined that early detection of the phenotype of asthma, the main significant risk factors for the development of uncontrolled asthma, reduced tolerance to physical activity, deterioration of the quality of life, the development of lung hyperinflation, the occurrence of severe exacerbations and the timely prescription of adequate basic therapy is the basis of secondary prevention of severe BA. Conclusions: conducted studies indicate that the definition of individual phenotypes of asthma, their clinical features, types of inflammation and concomitant diseases by prognosing method allows to determine the risk factors that significantly affect the severity of the course of asthma and is the basis for prescription of pathogenetically based anti-inflammatory and bronchodilator therapy.
Authors and Affiliations
Y. I. Feshchenko, L. A. Iashynа, K. V. Nazarenko, V. І. Ignatieva, S. G. Opimakh
Keywords
Related Articles
- EP ID EP511326
- DOI 10.31655/2307-3373-2019-1-9-14
- Views 123
- Downloads 0
DIAGNOSTIC VALUE OF METHODS FOR SENSITIZATION DETERMINATION IN PEOPLE WITH ALLERGIC RHINITIS (REVIEW OF LITERATURE AND OWN DAT
Objective was to review the literature on the diagnostic value of various methods for determining sensitization in patients with allergies, to study the parameters of the specificity and sensitivity of skin testing and l...
EVALUATION OF THE EFFICACY AND SAFETY OF COMBINED USE OF FORMOTEROL AND FLUTICASONE PROPIONATE IN THE TREATMENT OF PATIENTS WITH BRON-CHIAL ASTHMA AND COMORBID CORONARY HEART DISEASE
TAim: to evaluate the clinical efficacy and safety of the use of formoterol (Zafiron medicine, «Adamed Pharma S.A» pharmaceutical company) and fluticasone propionate (Flutixon medicine, «Adamed Pharma S.A» ph...
OPTIMIZATION OF EXTERNAL CARE IN CHILDREN OF EARLY AGE WITH SKIN SYMPTOMS OF FOOD ALLERGY
The article presents modern data on the organization of proper skin care in young children with skin manifestations of food allergy. The effectiveness of external care optimizing in children with skin manifestations of f...
FEATURES OF BRONCHIAL ASTHMA WITH NEUTROPHILIC INFLAMMATION
Bronchial asthma (BA) is a heterogeneous chronic inflammatory respiratory disease. Usually it is possible to achieve and maintain disease control in most patients. But there remains a part of...
THE ROLE OF SPIROMETRY IN THE DIAGNOSTICS OF BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Broncho-obstructive diseases (bronchial asthma (BA), chronic obstructive pulmonary disease (COPD)), despite certain success in their diagnostic and treatment still one of the leading problems of modern me...